1. Home
  2. VKTX vs HOG Comparison

VKTX vs HOG Comparison

Compare VKTX & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • HOG
  • Stock Information
  • Founded
  • VKTX 2012
  • HOG 1903
  • Country
  • VKTX United States
  • HOG United States
  • Employees
  • VKTX N/A
  • HOG N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • HOG Motor Vehicles
  • Sector
  • VKTX Health Care
  • HOG Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • HOG Nasdaq
  • Market Cap
  • VKTX 3.5B
  • HOG 2.8B
  • IPO Year
  • VKTX 2015
  • HOG N/A
  • Fundamental
  • Price
  • VKTX $23.09
  • HOG $29.82
  • Analyst Decision
  • VKTX Strong Buy
  • HOG Buy
  • Analyst Count
  • VKTX 12
  • HOG 7
  • Target Price
  • VKTX $87.50
  • HOG $30.00
  • AVG Volume (30 Days)
  • VKTX 6.8M
  • HOG 1.6M
  • Earning Date
  • VKTX 10-22-2025
  • HOG 10-23-2025
  • Dividend Yield
  • VKTX N/A
  • HOG 2.42%
  • EPS Growth
  • VKTX N/A
  • HOG N/A
  • EPS
  • VKTX N/A
  • HOG 1.93
  • Revenue
  • VKTX N/A
  • HOG $4,474,610,000.00
  • Revenue This Year
  • VKTX N/A
  • HOG N/A
  • Revenue Next Year
  • VKTX N/A
  • HOG $4.11
  • P/E Ratio
  • VKTX N/A
  • HOG $15.47
  • Revenue Growth
  • VKTX N/A
  • HOG N/A
  • 52 Week Low
  • VKTX $18.92
  • HOG $20.45
  • 52 Week High
  • VKTX $81.73
  • HOG $39.93
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 32.25
  • HOG 59.11
  • Support Level
  • VKTX $24.82
  • HOG $29.56
  • Resistance Level
  • VKTX $26.50
  • HOG $30.86
  • Average True Range (ATR)
  • VKTX 1.18
  • HOG 0.85
  • MACD
  • VKTX -0.20
  • HOG -0.16
  • Stochastic Oscillator
  • VKTX 2.47
  • HOG 49.47

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About HOG Harley-Davidson Inc.

Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring segments, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 37% of the heavyweight domestic market in 2024.

Share on Social Networks: